Journal Article Summary
The article examines the impact of the Inflation Reduction Act on out-of-pocket prescription drug costs for Medicare beneficiaries suffering from asthma and chronic obstructive pulmonary disease (COPD). High medication costs can lead to patients not taking their prescribed treatments, which can worsen their health outcomes. Understanding how recent legislative changes can alleviate these financial burdens is crucial for improving adherence to medication and overall health for these individuals.
The researchers analyzed data from the Medical Expenditure Panel Survey to identify Medicare beneficiaries aged 65 and older with asthma and/or COPD who had out-of-pocket drug expenses exceeding $2,000 per year. They found that approximately 5.2 million beneficiaries were affected, with 360,160 individuals spending more than $2,000 annually on medications. The study estimated that the Inflation Reduction Act could save these patients a median of $1,003 per year, and over 232,000 beneficiaries would qualify for new low-income subsidies, potentially reducing their costs even further.
Despite these promising findings, the study has limitations, including reliance on survey data that may not capture all beneficiaries accurately. Patients should be aware that while the Inflation Reduction Act aims to reduce their medication costs, individual experiences may vary. It is important for patients to discuss their specific situations and any concerns about medication adherence with their healthcare providers to ensure they receive the best possible care.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Mein Stephen A., Tale Archana, Rice Mary B., Narasimmaraj Prihatha R., Wadhera Rishi K.. Out-of-Pocket Prescription Drug Savings for Medicare Beneficiaries with Asthma and COPD Under the Inflation Reduction Act. Journal of General Internal Medicine 2024. DOI: 10.1007/s11606-024-09063-4. PMID: 39367288. PMCID: PMC11968625.
Featured Pill Pals Product
Acetaminophen 500 MG Caplets ---1,000 Count --- Generic For Tylenol --- Major / Rugby --- Over The Counter
Acetaminophen 500 MG Caplets —1,000 Count — Generic For Tylenol — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
